Pargyline
General information:
| Withdrawn ID: | 331 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | C02KC01 |
| Molecular Formula: | C11H13N |
| Molweight: | 159.228 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1982 |
| First withdrawn: | 2007 |
| Last withdrawn: | 2014 |
Filtered ChEMBL targets:
| Target UniProtKB ID | Activity in nm | Target Name | Target gene |
|---|---|---|---|
| O75604 | 5011.9 | Ubiquitin carboxyl-terminal hydrolase 2 | UBP2_HUMAN |
| P02545 | 8912.5 | Prelamin-A/C | LMNA_HUMAN |
| P16473 | 125.9 | Thyrotropin receptor | TSHR_HUMAN |
| P21397 | 1100 | Amine oxidase [flavin-containing] A | AOFA_HUMAN |
| P27338 | 8.2 | Amine oxidase [flavin-containing] B | AOFB_HUMAN |
Toxicity information:
| Toxicity class: | 3 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 265 mg/kg |
External links:
| ChEBML: | CHEMBL673 |
|---|---|
| DrugBank: | DB01626 |